www.3sbio.com 提示:

本信息仅供医学专业人士参考,如果您是医学专业人士,请点击确定后进入。 如果不是,请点击取消。

取消 确定
CN

Cherish Life, Care for Life, Create Life

Cherish Life, Care for Life, Create Life

Social Responsibility

Our Goal

3SBio has long incorporated healthcare accessibility into its long-term strategy. We believe that the true value of pharmaceutical innovation lies in enabling every patient to equitably enjoy the health benefits brought by technological advances. We are committed to continuously improving access to pharmaceutical and healthcare resources and advancing inclusive healthcare through a variety of initiatives, including R&D innovation, charitable donations, and physician training for grassroots communities.





Our Governance

3SBio positions healthcare accessibility as one of the central themes within its ESG governance framework. We have established a comprehensive management structure spanning from the Board of Directors to the executive level. As the supreme authority on healthcare accessibility, the Board of Directors oversees the overall implementation of this strategy, while the ESG Committee is responsible for the day-to-day management and advancement of this issue. This governance framework ensures that the access strategy is integrated into every aspect of the company’s decision-making and operations, thus continuously addressing the diverse needs of patients, physicians, health insurance providers, and the general public.

Our Achievements

  • Multiple core products included in the NRDL;
  • The Ankylosing Spondylitis Healthy Villages Program covers 30 provinces across China, with more than 1,300 contracted medical institutions, nearly 30,000 cumulative patients treated, and over 60,000 primary healthcare professionals trained
  • Multiple products have been included in authoritative clinical guidelines such as CSCO and KDIGO
  • Actively conduct real-world studies to provide data support for optimizing primary care diagnosis and treatment models